Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments. - Wikidata - wikimedia - TriplyDB

Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.

Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.

http://www.wikidata.org/entity/Q38210117

about

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Magneto-immunocapture with on-bead fluorescent labeling of amyloid-β peptides: towards a microfluidized-bed-based operation.Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.Metabolomic Analysis in Brain Research: Opportunities and Challenges Plasma β-amyloid in Alzheimer's disease and vascular disease.Recent applications of CE- and HPLC-MS in the analysis of human fluids.Risk factors and biomarkers of age-related macular degeneration.A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.Cerebrospinal Fluid from Alzheimer's Disease Patients Contains Fungal Proteins and DNA.Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.Metabolomics toward personalized medicine.Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease

P2860

Q30845482-052563C4-C190-4846-9132-FD26F9521EEC Q35709581-45E4E7DE-D6AD-4753-89A8-CBFB000EC230 Q36439886-D1F8A4A8-A419-4172-9E59-08A69CADF324 Q36930380-E8C25272-83B6-409E-AC88-2180818BBB65 Q36949501-D49C0948-0865-423C-AEF0-205FC9B75176 Q38596722-F6E20DE9-77D7-4B19-86FB-8BE8CC715304 Q38828895-80F11A98-CE88-46CF-80EC-158BD46EF990 Q40428596-777F26FB-27E5-4EBF-B421-07A800474BB7 Q40984218-5CED3FA1-41C3-452C-97DB-EBB7EEE0DCE7 Q47200597-8F128168-40DE-4EB5-98DB-6CFE6E9B2A00 Q50090010-2F1679E6-496A-4D3B-9256-BCA766BE9A0B Q57072685-CF4AFCDE-8680-4BC8-8302-CA6D248D7857 Q57493750-299205DD-BF02-49CE-B34B-8F50B42AF165

P2860

Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.

http://www.wikidata.org/entity/Q38210117

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cerebrospinal fluid analysis i ...... ssues and future developments.

@en

type

label

Cerebrospinal fluid analysis i ...... ssues and future developments.

@en

prefLabel

Cerebrospinal fluid analysis i ...... ssues and future developments.

@en

P1433

Q38210117-E5C392F9-B915-48F3-86C3-F76C1AB7257E

P1476

Q38210117-D8E562A2-9B76-48F8-9834-791836A8737B

P2093

Q38210117-294ECC2E-305D-449E-BBA3-655DDFC95F3E

P2860

Q38210117-0141A997-E7A9-4AF2-A45C-E303EA285716

Q38210117-023F662B-D467-45C4-B283-FAE2B6C542B0

Q38210117-0261E52F-39BD-410B-B2C5-3D0DEA8071DA

Q38210117-026C220C-B457-4790-A66A-BC6ADDB1C59F

Q38210117-0310CE72-61F5-416D-A02D-3243F8946444

Q38210117-0359FD98-6C1A-4F5C-BFA9-7A5904175BB6

Q38210117-0943D017-1CCB-4AD6-A261-59F41556E50D

Q38210117-1047F71B-D6A3-4E07-9CA3-38DDEAB81D3C

Q38210117-111DECFB-D775-472B-85C4-E35E04D9A4EE

Q38210117-1649C1AE-A5FA-4B03-83D5-F999AA05B8DC

P2888

Q38210117-050BDADD-B41E-4E22-A22F-C754F023C370

P304

Q38210117-5C27E12B-6CF4-4699-810D-DC35AE9BF466

P31

Q38210117-C0728966-2236-4B27-B8B0-63002C4FD78C

P356

Q38210117-53644C7C-F8EB-4CF4-9942-11D2FE820940

P433

Q38210117-11FCD0BF-4D0A-4551-B216-94F041C4C9D6

P478

Q38210117-BC38D996-B276-4F66-8EFD-50BA67D9897E

P50

Q38210117-03C6A497-3435-4D64-B0F7-D9236BE455F6

Q38210117-0C804C30-94DB-46FC-8C0D-A7D595E0190F

Q38210117-3EEA2ECF-B102-4F41-A1A9-6CC6CF918103

Q38210117-BA3CBA7A-F8A6-4A4A-ADBF-E0CEBD90143B

P577

Q38210117-7166AF7E-9E36-4251-B080-6FED47000681

P5875

Q38210117-6B2438F9-967B-4712-B3AE-734A68F494F2

P6179

Q38210117-DB8F1531-2ADA-4F26-B371-3BCA23FDED2F

P698

Q38210117-A2E59A99-B401-45D8-9A2F-A15BF68B9952

P921

Q38210117-0DC96240-28C3-45DA-A7A0-7D6A827DDB6D

Q38210117-EE3F7FAA-832F-4BE7-8348-F740AB509963

P356

S00415-014-7366-Z

P1433

Journal of Neurology

P1476

Cerebrospinal fluid analysis i ...... ssues and future developments.

@en

P2093

Simone Lista

http://www.w3.org/2001/XMLSchema#string

P2860

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update

TREM2 Variants in Alzheimer's Disease

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers

Mass spectrometry-based proteomics

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

P2888

s00415-014-7366-z

P304

1234-1243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-014-7366-Z

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

261

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

P577

2014-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262148708

http://www.w3.org/2001/XMLSchema#string

P6179

1030585854

http://www.w3.org/2001/XMLSchema#string

P698

24807087

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid